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Pseudomonas aeruginosa is an opportunistic pathogen responsible for chronic 
infections in patients with underlying injury and disease, such as those with burns 
and cystic fibrosis (CF). 1 Antibodies to a  variety of Pseudomonas  antigens are 
produced in  these  patients (1-4),  but the persistent  nature of their infections 
suggests that immune responses are frequently ineffective. The potential role of 
cell-mediated immunity in limiting Pseudomonas ~ infections has been suggested 
by the work of Pier and Markham (5) and Sorensen et al. (6, 7).  In the former 
study, protection of mice against bacterial challenge was afforded by the adoptive 
transfer of Thy-1 + spleen cells from Pseudomonas-immune  donors. In the latter 
series of reports, T  lymphocytes from CF patients in advanced stages of infection 
were shown to be  hyporesponsive to Pseudomonas  bacterial  challenge in vitro. 
Using crude soluble antigens prepared from several mucoid Pseudomonas strains, 
we too have observed unresponsiveness on the part of CF T  cells in vitro. 2 For 
this  reason  we  have  been  particularly  interested  in  identifying the  antigenic 
components  of the  microorganism  that  are  recognized  by T  cells  of normal, 
healthy individuals. 
A  number  of exoproducts  from P.  aeruginosa  have  been well  characterized 
with  regard  to  their  pathogenic  properties  (4,  8-12).  We  were  interested, 
therefore, in the potential antigenicity of these components for human T  cells, 
since  this  information  might  be  useful  in  identifying the  nature  of immune 
defects in CF. Our experimental approach has been to clone human T  lympho- 
cytes responding to the antigens in crude bacterial culture fluids and to test these 
clones for  reactivity  to  known Pseudomonas  antigens.  Clones  of Pseudomonas- 
immune T  cells were selected by limiting dilution and expanded with the aid of 
T  cell growth factor (TCGF). They were then analyzed with antigen panels that 
permitted enumeration of the most frequent clones and identification of their 
specificities. This approach not only has identified the relevant bacterial antigens, 
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but  has  yielded information on  the  immune repertoire diversities of several 
donors. The results indicate that immune human donors develop predominant 
repertoire  patterns  to  select  Pseudomonas  antigens,  including  two  proteases 
secreted by the organism. 
Materials and Methods 
Cell Preparations.  Mononuclear cells (MC) were isolated from the blood of healthy 
adult  immune donors by centrifugation through  Hypaque-Ficoll. Adherent  monocytes 
(M~) were prepared as previously described (13), except that M~s were irradiated (2,500 
rad; 137Cs) rather than being treated with mitomycin. 
Antigens.  Crude Pseudomonas  antigens consisted of sterile (0.22 #m Millipore filtered) 
culture supernatant fluids collected after 48 h of bacterial growth in trypticase soy broth. 
The bacterial growth medium was not antigenic for human T  cells.  Crude antigens were 
titrated  against  at  least  five immune  donors'  MCs  for  optimum tissue  culture  doses, 
(generally found to be 0.1-1 # 1/well). Pseudomonas alkaline protease (AP) and elastase (E) 
were purchased from Nagase Co, Ltd. (Tokyo) and Pseudomonas exotoxin A was prepared 
as previously described (14).  Inactivation of the enzyme activity of AP involved heating 
at 65 °C for 30 min (15,  16). Total protease activity was measured by the assay described 
by Rinderknecht et al. (17) using hide azure blue powder suhstrate, and elastolytic activity 
was  determined  as  previously described  (18).  Mumps,  tuberculin  PPD,  and  Candida 
albicans were purchased from commercial sources and used at doses reported earlier (13). 
Cloning of Pseudoraonas-specific  Human T  Cells.  Screening MC donors for immunity 
to Pseudomonas  involved culturing MC with various Pseudomonas antigens (Table I) under 
conditions previously described (13) and assessing tritiated thymidine ([SH]TdR) uptake 
7  d  later.  Donors  were  designated  highly  immune  if the  stimulation  index,  SI (cpm, 
antigen-stimulated cultures/cpm, control cultures) was >1'0. 
Monoclonal T  cell populations were isolated and propagated according to Lamb et al. 
(19)  with  the  following  modifications.  All  cloning  and  assay  medium  contained  10% 
human AB  + serum. After initial  stimulation with crude Pseudomonas  antigens for 6  d, 
lymphoblasts were purified by a two-step (35%, 45%) discontinuous Percoll gradient and 
plated  under  limiting dilution  conditions  (30-40  wells/dose)  in  Teresaki  Microtest  II 
plates (Falcon Labware, Oxnard, CA). Input cell doses ranged from 27 to 0.11  lympho- 
blasts/well. After 7 d, the contents of each well were transferred to a 200 #1 microculture 
and expanded for 7 additional days in the presence of 10-20% TCGF, antigen, and l0 s 
TABLE  I 
Characteristics of Pseudomonas  Strains Used in this Study 
Strain  Properties  Ref. 
GoM 
JoS 
Ka 
PAO-I 
PAO- 1-T 1 
PAO-1-E64 
PAO-I-1641 
Pa-103* 
Pa-103-29* 
Clinical isolate from cystic fibrosis patient 
Clinical isolate from cystic fibrosis patient (elastase 
deficient) 
Clinical isolate from cystic fibrosis patient 
Parental strain  20 
Exotoxin A-deficient mutant of PAO-1  13 
Altered elastase mutant of PAO-1  18 
Protease and elastase deficient mutant of PAO-1  * 
Protease-deficient parental strain  21 
Exotoxin A-deficient mutant of Pa- 103  22 
* Howe and Iglewski, unpublished observation. 
* While Pa-103 and Pa-103-29 produce low levels of AP when grown  under 
certain conditions (22), they failed to produce detectable amounts of AP when 
grown in TSB under the conditions used for this study. 1340  T  CELL-STIMULATING ANTIGENS OF PSEUDOMONAS AERUGINOSA 
irradiated, autologous MC. Wells then were scored for growth and Poisson analysis was 
used to identify those populations arising from single precursors (i.e.,  input  cell doses 
giving >37% negative wells).  Clones were expanded in  15-mm wells containing antigen, 
10% TCGF, and 106 autologous irradiated (2,500 rad, ~3~Cs) MC as feeder cells. Subclon- 
ing was performed in an analogous fashion on clones aa6, aa 10, if1, and dd3 (see Fig.  1) 
using an input cell dose of 0.33 cells/well and in all cases verified monoclonality. Typically, 
two passages (3-4 d each) in 15-mm wells were adequate to expand clones and subclones 
to populations of >2  x  l0  T cells,  at which  time they were frozen (-80°C)  in cloning 
medium containing 7.5% dimethyl sulfoxide. Subsequent expansion, when necessary, was 
always performed with autologous irradiated MC, antigen, and 10-20% TCGF. 
TCGF was prepared by stimulating tonsillar lymphocytes (108/ml) in 12-mm polystyrene 
tubes with 0.1% PHA-P (Difco Laboratories Inc., Detroit, MI); the reagent was diluted 
to a concentration of 10 mg/ml according to the manufacturer's instructions and further 
diluted  1:100 in culture medium). Culture supernatant fluids were recovered 48 h later, 
filter sterilized, and used without further purification. 
In Vitro Antigen-induced T Cell Proliferation.  Specificity assays with uncloned MC (105] 
well)  were  performed  in  96-well  flat-bottom plates  as  previously described  (13).  To 
determine the specificity of cloned T  cell populations, the cells were thawed, washed three 
times, and cultured  (1-2  X  104/well)  with irradiated  (2,500  rad), autologous adherent 
MSs (10~/well) and various antigens in 200-#I flat-bottom wells. Generally, better responses 
were obtained when the MSs were precuhured with antigen for 16-18 h before addition 
of the T cell clones to the wells. All specificity assays were performed with cloning medium 
(19) containing 10% human AB+ serum. Cultures were labeled with 1 #Ci [SH]TdR per 
well for 7 h after 3 d incubation at 37°C. The results are expressed as mean cpm -  1 SD 
for quadruplicate cultures. 
Limiting  Dilution  Analysis (LDA) of Clonal  T  Cell Frequencies.  A  two-stage LDA was 
used to maximize detection of proliferative activity. Immune MC were cultured  in 96- 
well round-bottom plates under limiting dilution conditions (3.1-50  x  10  s MC/well) in 
the  presence of excess (5  X  104) irradiated  (2,500  rad),  autologous MC  and  optimal 
concentrations of antigen. 7 d  later, each well was washed three times and the cells were 
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FIGURE  1.  Reaction  patterns  of 15  human T  cell clones from two donors selected and 
expanded with either GoM or JoS antigens (see Table I). The patterns are clustered so as to 
achieve maximum homology and are assigned specificities  that reflect, where possible, reactivity 
with purified Pseudoraonas exoproducts.  A positive reaction is one in which [SH]TdR uptake 
exceeded control levels by a factor of 10. PARMELY  ET  AL.  1341 
transferred to flat-bottom wells containing 25 ×  10 s irradiated autologous MC. After an 
additional 5  d  rest, antigen  was added and cultures were  labeled 2  d  later with  1 #Ci 
[SH]TdR  for  7-8  h.  Controls consisted of MC  cultured at the  same  cell doses in  the 
presence  of feeder cells, but  stimulated with  antigen  only during the  second  in  vitro 
challenge.  For all data points,  24-36  replicate wells were  assayed.  Wells were  scored 
positive if the uptake of [SH]TdR exceeded that of control cultures by 3 SD. Cell doses in 
which all wells were positive were not included in the frequency calculations. The data 
were then plotted as the fraction of negative wells as a function of input cell dose by the 
least  squares  method.  Frequencies  were  extrapolated  for  F0  =  0.37  and  correlation 
coefficients and y-intercepts were calculated. The final statistic served as a measure of the 
number of interacting cell types being titrated. 
Results 
To  assure  that  a  wide  range  of potential  Pseudomonas antigens  could  be 
examined,  we  prepared  crude  culture  supernatant  fluids  from  nine  mucoid 
strains, three recovered from cystic fibrosis patients and six that previously had 
been characterized for their pathogenicity and secreted exoproducts (13,  18, 
20-22).  Some of the known attributes of these bacterial strains are shown in 
Table I. Of particular interest were those strains that failed to secrete proteases 
or toxins, because these would be useful in implicating specific products as T cell 
antigens. 
The antigen preparations were then used to stimulate blood MC from a large 
number of immune donors.  Results with six  representative donors (Table  II) 
revealed that most of the preparations were highly mitogenic. Additional exper- 
iments not reported here showed that proliferative responses were adherent cell 
dependent, reached maximum levels on days 6-7 of culture, and were mediated 
by E rosette-forming lymphocytes. -20%  of the normal donors tested showed 
reactivity to one or more of the antigens listed in Table II. Only an occasional 
donor was immune to the protease-deficient Pa-103  preparation,  whereas the 
majority of immune donors responded to PAO-1  (a normal protease-producing 
strain).  This  implied  that  one  or  more  of the Pseudoraonas proteases  was  a 
common antigen. 
In an attempt to identify the bacterial antigens responsible for this activity, T 
TABLE  II 
T Cell Proliferative  Responses*  of Six Immune Donors to a Panel of Pseudomonas  Antigens 
Antigen*  Mononuclear cell donors 
1  2  3  4  5  6 
--  59  506  172  219  141  2,618 
GoM  8,555  48,812  33,308  50,525  44,098  48,869 
JoS  48,974  74,000  11,924  14,724  11,310  31,725 
Ka  544 |  70,458  13,408  57,911  33,516  64,038 
PAO-1  37,500  79,159  8,489  21,005  36,971  71,981 
Pa-103  69  i  1,266 i  265 °  1,038 !  2,890  13,473! 
* Mean cpm SH-TdR uptake assessed 7-d after initiation of MC cultures. Data represents the optimum 
responses observed when several doses of the antigens were tested. 
* All antigens  were  crude  48-h  sterile culture  supernatant  fluids  from  growing bacteria.  The 
bacteriological medium (trypticase soy broth) was nonantigenic. 
! Responses differing from controls (without antigen) by a factor less than 10. 1342  T  CELL-STIMULATING  ANTIGENS  OF  PSEUDOMONAS  AERUGINOSA 
cells from donors 1 and 2 (Table II) were selected with the GoM or JoS antigens 
and cloned by limiting dilution.  Limiting dilution cloning after only 6  d  of in 
vitro  stimulation  assured  recovery of a  large number of clones with  diverse 
antigen specificities. 
Monoclonal populations  were then  expanded  with  a  minimum number of 
passages (usually only 3) to large numbers (~2  x  107) and frozen in dimethyl 
sulfoxide-containing medium. Aliquots were later thawed, washed, and assayed 
for specificity in the presence of freshly prepared autologous antigen-presenting 
MSs.  29  clones  were initially  isolated  from  these two  donors  and  tested  for 
specificity. Approximately half (i.e., 14) were unreactive or very weakly reactive 
to Pseudomonas antigens in the absence of TCGF.  15 Pseudomonas-specific clones 
were identified that reacted (SI >  10) with the antigens listed in Table I. None 
of these T  cells responded to antigens in the absence of MSs. 
Fig.  1 shows those reactions that were useful in distinguishing between differ- 
ent  clones.  The  figure  also  groups  the  clones  into  five  subsets,  presumably 
representing distinct antigenic determinants (here designated AP-1, AP-2, AP- 
3, E, and PAX). 12 clones reacted with purified Pseudomonas alkaline protease 
(AP) and two of these showed a weak cross-reactivity with elastase (E). One clone 
(f6) reacted selectively with elastase (E).  Three distinct AP determinants were 
implied by the data and these together constituted the most frequent specificities. 
For example, determinant AP-1 was present in both GoM and JoS crude antigens 
and on the purified AP molecule. By contrast, AP-3 was present on pure AP and 
in the crude JoS preparation, but was lacking in the GoM crude antigen. 
A titration of AP against clone GoMaa6 as well as the donor's uncloned MCs 
revealed  that  AP  was  antigenic  at  very  low  concentrations  (~1  ng/ml)  and 
stimulated vigorous proliferative responses (Fig. 2). These responses were adher- 
ent cell dependent and could be elicited with AP-pulsed M$s (data not shown). 
Since the antigen AP was proteolytic, we wanted to exclude the possibility that 
its mitogenicity was dependent simply on its enzymatic activity. Heat treatment 
of the enzyme (65°C for 30  min) reduced caseinolytic activity 1,600-fold, but 
only partially affected antigenicity (Fig.  3).  Proliferative responses to AP were 
suboptimal at doses >10 -I #g/well and declined to background levels when doses 
were increased above  1 #g/well. This inhibition was apparently attributable to 
enzyme-dependent toxicity, because heat inactivation of the protein reversed the 
effect. Moreover, addition of high doses of AP to mumps-stimulated cultures 
inhibited anti-mumps responses as well (Fig. 4). Here too, the immunosuppressive 
effect was reversed when the AP was first heat treated. 
The  finding that  so  many clones from these two donors were AP  specific 
implied that immunity to the protease might be common among Pseudomonas- 
immune donors. Indeed, four of the six donors included in this study were highly 
immune to the antigen (Table III).  To test the hypothesis that AP-specific T 
cells are frequent among T  cells committed to Pseudomonas antigens, we mea- 
sured clonal frequencies by LDA. Dilutions of MC from known immune donors 
were cultured either with AP,  PAO-1, JoS, or mumps antigens for 7  d.  Then 
the cells were washed, rested on fresh irradiated MC, and restimulated with the PARMELY ET  AL.  1343 
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FIGURE 2.  Responses  of uncloned cells and clone GoMaa6 (both from donor number 1, 
Table II) to AP and Exotoxin A. 
homologous antigen.  Proliferation was assessed 2 d  later.  A  typical experiment 
(Fig.  5) revealed that  the frequencies of AP-specific proliferating  T  cells were 
comparable to the frequencies of T  cells committed to all secreted Pseudomonas 
antigens in the crude PAO-1 preparation.  This was a  consistent finding (Table 
IV). The  frequencies obtained were also comparable to those calculated for T 
cells reacting to non-Pseudomonas  antigens (e.g., mumps antigen,  exp.  5; refer- 
ences  23,  24).  Values  for y-intercepts  (y =  0.84-1.06)  indicated  that  a  single 
precursor cell type was being titrated. 
As a  final test of the hypothesis that most of the T  cells of these donors were 
reacting to AP secreted by Pseudomonas  organisms,  we cloned cells from donor 
5 (Table III), using AP as the selecting antigen. We predicted that clones obtained 
in this manner  should show specificity for AP and express the same specificity 
for the crude antigen panel (Fig.  1) as did the AP-specific clones initially selected 
with crude antigens.  This was indeed the case. Table V summarizes data on six 
such clones. Five showed reactivity to the GoM, JoS, PAO-1, and AP antigens, 
while failing to respond to the Ka,  Pa-103,  or E antigens  (i.e., they were AP-1 
specific; see Fig.  1). Therefore, by selecting clones with either pure AP or crude 
Pseudomonas  antigens, we obtained T  cells with the same apparent specificities. 1344  T  CELL-STIMULATING  ANTIGENS  OF  PSEUDOMONAS  AERUGINOSA 
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FIGURE 3.  Effect of heat inactivation of AP on its mitogenicity. O, alkaline protease; O, heat 
treated (65 C/30 rain) AP; A, E. Reported are proliferative responses of clone GoMaa6. 
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FIGURE 4.  Heat inactivation of AP destroys its high dose immunosuppressive activity. Cells 
from a donor immune to mumps antigens, but showing no response to AP, were cultured with 
mumps antigens and various doses of AP (I) or heat-inactivated AP (O). [SH]TdR uptake was 
assessed 7 d later. •  and A, cultures with AP or heat-treated AP, respectively, but no mumps 
antigens. [] and I, control response with and without mumps. 
Discussion 
Many  human donors  recognize  AP  as  the  predominant  T  cell-stimulating 
immunogen secreted by Pseudomonas  organisms. Several lines of evidence sup- PARMELY  ET  AL. 
TABLE  Ill 
Uncloned Cells  from Pseudomonas-immune Donors Respond to 
Alkaline Protease 
1345 
MC donors* 
[SH]Thymidine uptake (cpm X  l0  s) 
No antigen  AP (10  -I #g per well) 
1  1.9±0.4  110.9±10.2 
2  0.3±0.1  135.1±7.1 
3  0.2±0.1  41.1±14.3 
4  0.2±0.2  1.9±3.3 
5  0.2±0.2  29.2±8.2 
6  2.6±1.2  1.5±0.7 
* Same as in Table II. 
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FIGURE 5.  Limiting dilution measurement of the frequencies (F0) of proliferating T  cells 
specific for AP (O) or PAO-1 (O) antigens. 
TABLE  IV 
Limiting Dilution Measurement of the Frequency of T Cells Specific  for AP 
and Other Pseudomonas Antigens in Peripheral Blood 
Exp.  Antigen  Clonal frequency  r*  y-intercept* 
I  PAO-I  1.8 x  10  -5 (1/56,453)  0.97  1.02 
AP  1.9 x  10  -5 (1/51,348)  0.99  0.96 
2  JoS  2.4 x  10  -5 (1/42,511)  0.94  1.01 
AP  2.6 x  10  -5 (1/37,890)  0.99  0.96 
3  PAO-I  6.0 ×  10  -5 (1/16,703)  0.94  0.84 
AP  2.7 ×  10  -5 (1/37,090)  0.99  1.03 
4  JoS  1.3 x  10  -5 (1/75,801)  0.99  1.05 
AP  2.5 ×  10  -5 (1/39,795)  0.94  1.00 
5  AP  1.5 ×  10  -5 (1/67,454)  0.99  1.06 
6  Mumps  3.3 ×  10  -5 (1/30,135)  0.98  0.94 
* r, correlation coefficient. At least 4 points were used to define each line. 
* y-intercept values approaching 1.0 indicate titration of a single cell type. 1346  T  CELL-STIMULATING  ANTIGENS OF PSEUDOMONAS AERUGINOSA 
TABLE  V 
Fine Specificity of AP-Specific T Cell Clones 
Lymphoproliferative  response* 
Antigen* 
Clone:  ee2  ee 10  if9  bb2  ee5  ee6 
--  8  21  31  13  19  67 
GoM (0.4)  31,673  17,572  1,522  63  339  231 
JoS (2.0)  7,884  5,100  497  329  253  84 
Ka (0.4)  35  141  54  18  9  103 
PAO-1 (0.4)  40,018  25,669  2,343  3,618  200  308 
Pal03 (2.0)  21  81  3  9  14  17 
AP (10  -2 #g)  121,419  46,948  46,948  30,070  59,200  26,902 
E (10-2 #g)  52  22  8  22  117  12 
TCGF (20%)  80,053  70,184  18,726  38,584  63,580  43,340 
* Doses in parentheses  are #1 or #g/well. 
*  Assessed by 3H-TdR uptake on d3. 
port this conclusion. First, soluble crude antigens prepared from Pseudomonas 
strains that were known to produce little or no protease (e.g.  Pa-103,  Pa-103- 
29, and PAO-1-1641; reference 22 and Howe and Iglewski, unpublished obser- 
vations) have consistently failed to stimulate MCs from most donors tested to 
date. This did not appear to reflect nonspecific toxicity of the preparations, since 
they did not inhibit MC responses to non-Pseudomonas antigens. Second, mono- 
clonal T cells selected for reactivity to soluble crude Pseudomonas antigens reacted 
specifically with purified AP at fairly low doses (10-1-10 -5 t~g/ml). Pure AP also 
stimulated uncloned MC from four of the six donors included in this report. 
Third, when absolute measurements of the frequencies of AP-specific blood T 
cells were made, we found that these were not trivial clones that had simply 
survived  the  pressures  of  in  vitro  selection.  Rather,  their  numbers  among 
uncloned cell populations were comparable to the frequencies of T  cells com- 
mitted to all released Pseudomonas antigens of the JoS and PAO-1 strains. These 
values (1/67,454-1/37,090  MC) are also comparable to published data on the 
frequencies of human  blood  T  cells  specific  for  streptokinase-steptodornase, 
tetanus toxoid,  tuberculin  PPD,  and  keyhole limpet  hemocyanin (23-26).  It 
should be noted, however, that frequencies calculated in this manner represent 
minimum  values,  particularly  for  the  crude  antigens  that  contain  inhibitory 
substances, such as endotoxin, that might interfere with the detection of  antigen- 
reactive  T  cells  (13).  Finally,  we  selected  clones  from Pseudomonas-immune 
donors with  AP  and re-tested  these  for reactivity against the panel  of crude 
antigens. Clones with the same specificity patterns were obtained regardless of 
whether they were selected with crude or purified AP antigens. 
We have considered the possibility that the purified AP used in this study was 
contaminated with another antigen, particularly Pseudomonas E. However, direct 
measurements of  the two enzyme activities have detected <0.1% E contamination 
of the AP preparation. Three additional observations argue against E contami- 
nating the  AP.  First,  very small quantities of purified AP  were antigenic for 
many of the clones (e.g.,  10  -2 ng/ml), whereas elastase-specific clones, like f6, 
typically showed optimal responses at doses of 10-2-10 -~ #g E/ml. Therefore, a 
minor E contaminant in the AP probably would have been insufficient to activate PARMELY  ET  AL.  1347 
the cells.  Second, at  least  one  strain  of bacteria  included in  this  study (Ka) 
produced very high  levels of E  but  was  nonantigenic for AP-specific clones. 
Third, although two AP-2 specific clones cross-reacted with E, responses to E 
were modest (i.e., mean cpm [3H]TdR uptake for AP and E were approximately 
42,000 and 6,000, respectively). This is not to say that Pseudomonas E is not an 
important antigen. In fact, clone f6 (Fig. 1), which did not react with AP, reacted 
vigorously with crude Ka antigen and pure E. Recent analysis of cells from donor 
6 (Table II) selected with the PAO-1 antigens has revealed a preponderance of 
E-specific clones (data not shown). 
A number of observations reported here can be explained by postulating that 
allotypic variations exist between the proteases produced by different Pseudo- 
monas strains. For example, clone aa6 recognized a determinant (designated AP- 
1) present on AP molecules secreted by GoM and JoS strains. By contrast, the 
AP produced by the GoM strain apparently lacked the AP-3 determinant (Fig. 
1). The presence of  allotypic markers capable of distinguishing between different 
Pseudomonas strains suggests that T  cell clones may prove useful as monoclonal 
typing reagents in defining antigens associated with pathogenicity traits. Alkaline 
protease has been implicated in animal models as a  virulence factor in Pseudo- 
monas infections (12,  27-31),  although to our knowledge allotypic variants of 
the molecule have not heretofore been described. Such information may prove 
important in identifying bacterial properties and altered host immune responses 
that permit chronic Pseudomonas infections like those in CF.  In this regard it is 
significant that CF patients' blood MC failed to mount proliferative response to 
Ka and JoS crude antigens despite ongoing pulmonary Pseudomonas infections.  2 
Because CF patients are known to produce antibodies to AP and E (3),  these 
findings suggest that protease-specific T  cells may be involved in limiting such 
infections. 
Summary 
To aid in understanding the role of cellular immunity in limiting Pseudoraonas 
aeruginosa infections, we have identified some of the principal antigens of the 
organism that are recognized by human T  cells. Clones of T  cells were selected 
in such a manner that they would provide information not only about the identity 
of Pseudomonas antigens, but also the T  cell repertoires of immune donors. Most 
clones were found to be specific for Pseudoraonas  alkaline protease (AP). Such 
clones could be physically isolated by selecting with crude Pseudoraonas  antigens 
or purified AP. In either case, their fine specificities were the same when tested 
against a panel of Pseudomonas antigens. The conclusion that AP is the principal 
immunogen for many donors was confirmed by measuring the absolute frequen- 
cies of proliferating T  cells committed to AP and all other Pseudoraonas antigens. 
Frequencies of AP-specific clones (1.5-2.7  x  10  -5)  were comparable to those 
from the same donors that were specific for all secreted Pseudomonas antigens 
(1.3-6.0  x  10-5).  These results provide a  model system for studying human T 
cell-mediated immunity to bacteria by identifying discrete antigens and measur- 
ing the repertoire diversities of cells responding to them. 
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